COVID-19 Vaccine Update

UPDATE (6-18-2022): FDA Authorizes & CDC/ACIP expands eligibility for COVID-19 vaccines to infants and children 6 months and older.

• Added guidance for a three dose primary series of the Pfizer-BioNTech COVID-19 vaccine (3 microgram each dose (maroon cap and label) for infants and children 6 months through 4 years of age) (two doses separated by 21 days (3 weeks), followed by a third dose at least 8 weeks after the second dose).
• Added guidance for a two dose primary series of the Moderna pediatric COVID-19 vaccine (25-microgram each dose) for infants and children 6 months through 5 years of age (two doses separated by 28 days).
• CDC will consider use of the Moderna COVID-19 vaccine in children 6 – 17 years old at its June 21-23, 2022, meeting.

UPDATE: (5-19-2022): FDA Authorizes & CDC/ACIP expands eligibility for COVID-19 vaccine boosters for children 5-11 years who received their primary series (first 2 vaccines) > 5 months ago.

As of 3/30/22 the CDC and FDA have approved a 4th dose (2nd booster) for adults aged 50 years and above.

Hours of Operation:

Monday through Friday - 9:00 am to 7:00 pm

Saturdays - 9:00 am to 3:00 pm

We appreciate your patience as we all work through this difficult time together, we are making these temporary changes in order to keep everyone in the community as safe as possible while still being here to serve you.

We thank you for your understanding!